Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Biomarkers. 2018 Dec 12;24(1):76–90. doi: 10.1080/1354750X.2018.1508308

Figure 5. Determination of candidate circulating miRs in dermal exposed/sensitized followed by nose-only MDI-aerosol challenged murine model.

Figure 5.

(A) Experimental timelines showing MDI exposed time points, routes. Expression levels of candidate circulating (B) mmu-miR-183-5p, (C) mmu-miR-206-3p, and (D) mmu-miR-381-3p were compared to control mice without dermal and airway MDI-aerosol exposure control (N=3; bars, s.e.m.). MDI: 4,4’-methylene diphenyl diisocyanate; ACN: acetone. (***P<0.001).